ApoXcel AB
ABActiveOrg 5593341497Kvarngatan 23, 692 34 KumlaRetail sale of pharmaceutical products· NACE 4773Est. 2021 · 5 years old2 employees
Loading company…
Overview
ApoXcel AB is a Swedish AB based in Kumla, operating in the Retail sale of pharmaceutical products sector. Incorporated in 2021, the company has 2 employees and reported revenue of SEK 22.4m in its latest annual filing.
Revenue 2025
22.4M SEK
+10% vs 2024
EBITDA margin
1.8 %
−73% vs 2024
Net profit 2025
0M SEK
-98% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
14.7 %
Very weakAmong the 20% lowest rated companies in the industry
20222025
Liquidity ratioCurrent assets ÷ Short-term debt
1.1×
Very weakAmong the 20% lowest rated companies in the industry
20222025
Return on assets (ROA)Net profit ÷ Total assets × 100
0.2 %
AverageAround the average of companies in the same industry
20222025
EBITDA — year on year
SEK thousandsKey figures
Annual report 2025| Revenue | 22.4M SEK | +10% |
| EBITDA | 0.4M SEK | -73% |
| Net profit | 0M SEK | -98% |
| Total assets | 7.1M SEK | +15% |
| Equity | 1M SEK | -18% |
| Employees | 2 | — |
Company information
Legal name
ApoXcel AB
Org number
5593341497
Legal form
Aktiebolag
NACE code
Founded
8 September 2021 · 5 years
Share capital
SEK 100,000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva handel med receptbelagda apoteksvaror, receptfria apoteksvaror och handelsvaror som lämpar sig för försäljning och distribution till konsumenter genom apotek samt därmed förenlig verksamhet.
(no translation available)
Contact
Address
Kvarngatan 23, 692 34 Kumla
Email
humanyun_pu@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), ApoXcel AB reported revenue of SEK 22.4m, an increase of 10% on the year before. The figures on this page draw on 4 annual filings covering 2022 to 2025. The bottom line showed a net profit of SEK 15.0k, and the EBITDA margin stood at 1.8%.
At the end of 2025, equity financed 14.7% of the balance sheet, and current assets covered short-term debt 1.1 times.
Financials
Revenue
SEK millionsEBITDA
SEK thousandsIncome statement
SEK thousands| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 22,369 | 20,357 | 11,069 | 3,582 |
| Staff expenses | -1,184 | -1,441 | -971 | -686 |
| EBITDA | 407 | 1,491 | 417 | -437 |
| Depreciation & amort. | -273 | -273 | -273 | -104 |
| EBIT | 134 | 1,218 | 144 | -541 |
| Net financials | -110 | -182 | -245 | -110 |
| Profit before tax | 24 | 1,011 | 0 | — |
| Tax | -9 | -79 | — | — |
| Net profit | 15 | 932 | 0 | -651 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
SEK thousands| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | 7,093 | 6,161 | 4,754 | 3,462 |
| Equity | 1,046 | 1,281 | 349 | 349 |
| Long-term debt | 250 | 789 | 1,274 | 1,478 |
| Short-term debt | 5,798 | 4,091 | 3,130 | 1,635 |
| Total debt | 6,048 | 4,880 | 4,404 | 3,112 |
Financial ratios
5-year trendEBITDA margin
1.8 %
20222025
Equity ratio
14.7 %
Very weakAmong the 20% lowest rated companies in the industry
20222025
Return on equity
1.4 %
AverageAround the average of companies in the same industry
20222025
Net profit margin
0.1 %
WeakAmong the 40% lowest rated companies in the industry
20222025
Asset turnover
3.15×
StrongAmong the 30% highest rated companies in the industry
20222025
Debt / equity
5.78×
Very weakAmong the 20% lowest rated companies in the industry
20222025
Sector performance
28 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginWeak
Among the 30% lowest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginWeak
Among the 40% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginWeak
Among the 40% lowest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Average
Around the average of companies in the same industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Average
Around the average of companies in the same industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Average
Around the average of companies in the same industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Average
Around the average of companies in the same industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioAverage
Around the average of companies in the same industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioVery weak
Among the 20% lowest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioWeak
Among the 40% lowest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioWeak
Among the 30% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityVery weak
Among the 20% lowest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalWeak
Among the 40% lowest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioVery strong
Among the 10% highest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioVery weak
Among the 20% lowest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery weak
Among the 20% lowest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityVery weak
Among the 20% lowest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityVery weak
Among the 20% lowest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtWeak
Among the 40% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtAverage
Around the average of companies in the same industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageAverage
Around the average of companies in the same industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtWeak
Among the 30% lowest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginWeak
Among the 40% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverStrong
Among the 30% highest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverWeak
Among the 30% lowest rated companies in the industry
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalAverage
Around the average of companies in the same industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityWeak
Among the 30% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtWeak
Among the 30% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-08 – 2022-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JL Chief Auditor | Chief Auditor | 2022 |
JK Chief Auditor | Chief Auditor | 2025 |
HI Chief Executive Officer | Chief Executive Officer | 2022 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NH Deputy Board Member | Deputy Board Member | 2022 |
HI Board of Directors | Board of Directors | 2022 |
Former (12)
VE Deputy Board Member | Deputy Board Member | 2021 – 2022 |
IM Deputy Board Member | Deputy Board Member | 2021 – 2022 |
JT Deputy Board Member | Deputy Board Member | 2021 – 2022 |
AC Deputy Board Member | Deputy Board Member | 2021 – 2022 |
ES Deputy Board Member | Deputy Board Member | 2021 – 2022 |
AC Deputy Board Member | Deputy Board Member | 2021 – 2022 |
OK Deputy Board Member | Deputy Board Member | 2021 – 2022 |
JA Deputy Board Member | Deputy Board Member | 2021 – 2022 |
EM Deputy Board Member | Deputy Board Member | 2021 – 2022 |
AM Deputy Board Member | Deputy Board Member | 2021 – 2022 |
LA Board of Directors | Board of Directors | 2021 – 2022 |
MS Deputy Board Member | Deputy Board Member | 2021 – 2022 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 99% | 99% | 2025 |
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Apolans AB
ApoXcel AB Board network connections
Board members of ApoXcel AB also hold positions in 9335 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Anders Larsson | Board of Directors | 4,115 companiesMany roles |
| Jan Anders Fredrik Lovén | Deputy Board Member | 1,897 companiesMany roles |
| Anna Matilda Sjödin | Deputy Board Member | 867 companiesMany roles |
| Jan Totte Dahlin | Deputy Board Member | 650 companiesMany roles |
| Viktor Elias Bergman Gullmark | Deputy Board Member | 516 companiesMany roles |
| Emma Maria Birgitta Wik | Deputy Board Member | 514 companiesMany roles |
| Mari Sinikka Kovaniemi Feldt | Deputy Board Member | 506 companiesMany roles |
| Jon Karl Lahiru Nilsson | Chief Auditor | 93 companiesMany roles |
| Olina Kristina Maria Wåhlstedt | Deputy Board Member | 72 companiesMany roles |
| Anna Camilla Biström | Deputy Board Member | 69 companiesMany roles |
| Anna Carolina Maria Bjarnhagen | Deputy Board Member | 27 companiesMany roles |
| Jonas Lars Lindgren | Chief Auditor | 7 companiesMany roles |
| Humayun Iqbal | Chief Executive Officer | 1 company |
| Nyla Humayun | Deputy Board Member | 1 company |
Frequently asked questions
What is the Org number of ApoXcel AB?
ApoXcel AB is registered with Bolagsverket / SCB under Org 5593341497.
What is the revenue of ApoXcel AB?
ApoXcel AB reported revenue of SEK 22.4m in 2025.
How many employees does ApoXcel AB have?
ApoXcel AB employs 2 people as of the latest annual report.
Who is the CEO of ApoXcel AB?
Humayun Iqbal is the CEO of ApoXcel AB, in role since 2022.
Where is ApoXcel AB headquartered?
ApoXcel AB's registered address is Kvarngatan 23 Lgh 1104.